0001209191-21-037144.txt : 20210602 0001209191-21-037144.hdr.sgml : 20210602 20210602161143 ACCESSION NUMBER: 0001209191-21-037144 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210601 FILED AS OF DATE: 20210602 DATE AS OF CHANGE: 20210602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heyman Richard A. CENTRAL INDEX KEY: 0001584759 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39539 FILM NUMBER: 21989229 MAIL ADDRESS: STREET 1: 5871 OBERLIN DRIVE, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PMV Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001699382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463218129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 642-6664 MAIL ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-01 0 0001699382 PMV Pharmaceuticals, Inc. PMVP 0001584759 Heyman Richard A. C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512 1 0 0 0 Common Stock 2021-06-01 4 M 0 1950 2.95 A 1950 I See footnote Common Stock 2021-06-01 4 S 0 1392 32.1509 D 558 I See footnote Common Stock 2021-06-01 4 S 0 553 33.6105 D 5 I See footnote Common Stock 2021-06-01 4 S 0 5 34.67 D 0 I See footnote Common Stock 2021-06-01 4 M 0 975 2.95 A 975 I See footnote Common Stock 2021-06-01 4 S 0 743 32.1618 D 232 I See footnote Common Stock 2021-06-01 4 S 0 230 33.7465 D 2 I See footnote Common Stock 2021-06-01 4 S 0 2 34.67 D 0 I See footnote Common Stock 2021-06-01 4 M 0 975 975.00 A 975 I See footnote Common Stock 2021-06-01 4 S 0 764 32.1507 D 211 I See footnote Common Stock 2021-06-01 4 S 0 209 33.7882 D 2 I See footnote Common Stock 2021-06-01 4 S 0 2 34.67 D 0 I See footnote Stock Option (right to buy) 2.95 2021-06-01 4 M 0 1950 0.00 D 2027-08-16 Common Stock 1950 15901 I See footnote Stock Option (right to buy) 2.95 2021-06-01 4 M 0 975 0.00 D 2027-08-16 Common Stock 975 7951 I See footnote Stock Option (right to buy) 2.95 2021-06-01 4 M 0 975 0.00 D 2027-08-16 Common Stock 975 7951 I See footnote Stock Option (right to buy) 2.95 2027-08-16 Common Stock 11901 11901 D The shares are held of record by Paul L. Vogel as Trustee of the Heyman Family 2020 Irrevocable Trust under agreement dated August 31, 2020 for the benefit of the Reporting Person's immediate family. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.01 to $32.815, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (6), (7), (9) and (10) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.055 to $33.875, inclusive. The shares are held of record by Paul L. Vogel as Trustee of the Julia E. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's daughter and descendants. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.02 to $32.46, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.62 to $33.875, inclusive. The shares are held of record by Paul L. Vogel as Trustee of the Scott Z. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's son and descendants. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.815, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.62 to $33.875, inclusive. All of the shares subject to the option are vested and immediately exercisable. The shares subject to the option are subject to an early exercise provision and are immediately exercisable. One forty-eighth of the shares subject to the option vested on September 17, 2017, and an additional one forty-eighth of the shares subject to the option shall vest each month thereafter. /s/ Winston Kung, by power of attorney 2021-06-02